Skip to main content
Log in

Malignant pheochromocytoma. Effect of oral α-methyl-p-tyrosine upon catecholamine metabolism

Malignes Phäochromocytom. Wirkung von α-Methyl-p-Tyrosin auf den Catecholamin-Stoffwechsel

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Bei einem Patienten mit malignem Phäochromocytom führte die Behandlung mit α-methyl-p-Tyrosin zu einer fast vollständigen Normalisierung des Blutdrucks. Propranolol und Phenoxy-benzamin waren vorher ohne großen Erfolg angewendet worden. Das Allgemeinbefinden des Patienten besserte sich beträchtlich. Während der Behandlung fielen die Ausscheidungsraten von Catecholaminen und ihren Metaboliten auf ca. 50% der Werte vor Behandlung ab. Der Nachweis von α-Methyldopa und α-Methylnormetanephrin bewies die Möglichkeit der o-Hydroxylierung von α-methyl-p-Tyrosin. Nach Beendigung der Behandlung stiegen Blutdruckwerte und Ausscheidung von Catecholaminen innerhalb von 2 Tagen wieder in die vor Behandlung gefundenen hochpathologischen Bereiche an.

Summary

In a patient with malignant pheochromocytoma treated unsuccessfully with propranolol and phenoxybenzamine the additional therapy with α-methyl-p-tyrosine resulted in a substantial decrease of the blood pressure to almost normal values. His general condition improved considerably. During therapy the urinary excretion rates of catecholamines and all their metabolites dropped to about 50% of control values. O-Hydroxylation of α-methyl-p-tyrosine could be demonstrated by the isolation of α-methyldopa and α-methylnormetanephrine. After discontinuation of treatment with α-methyl-p-tyrosine blood pressure and catecholamines returned to control values within two days.

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  • Bischoff, F., Torres, A.: Clin. Chem.8, Determination of urine dopamine. 370–377, (1962)

    PubMed  Google Scholar 

  • Brodie, H.K.H., Murphy, D.L., Goochrin, F.K., Bunny, W.E. jr: Clin. Pharmacol. Ther.12, Catecholamines and mania: The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism. 218–224 (1971)

    PubMed  Google Scholar 

  • Carlsson, A., Lundborg, P., Stitzel, R., Waldeck, B.: J. Pharmacol. Exp. Ther.158, Uptake, storage and release of3H-α-methylnoradrenaline. 175–182 (1967)

    PubMed  Google Scholar 

  • Crout, J.R.: Pheochromocytoma. Pharm. Rev.18, 651–658 (1966)

    PubMed  Google Scholar 

  • Dengler, H.J.: Erg. Labor-Med.3, Zur Methodik der Katecholaminbestimmung beim Phaeochromocytom. 55–63 (1967)

    Google Scholar 

  • Engelman, K., Jéquier, E., Udenfriend, S., Sjoerdsma, A.: Metabolism of α-methyltyrosine in man: Relationship to its potency as an inhibitor of catecholamine biosynthesis. J. clin. Invest.47, 568–576 (1968)

    PubMed  Google Scholar 

  • Euler, U.S. v., Zetterström, B.: The rôle of amine oxidase in the inactivation of catecholamine injected in man. Acta physiol. Scand.33, 26–31 (1955)

    PubMed  Google Scholar 

  • Gugler, R., Knuppen, R., Breuer, H.: Reinigung und Charakterisierung einer S-Adenosylmethionin: Catechol-O-Methyltransferase der menschlichen Placenta. Biochim. Biophys. Acta222, 10–21 (1970)

    Google Scholar 

  • Hengstmann, J.H.: Habilitationsschrift, Universität Bonn 1976

  • Hengstmann, J.H., Dengler, H.J.: Evidence for extratumoural storage of catecholamines in pheochromocytoma patients. Acta Endocrinol.87, 589–595 (1978)

    PubMed  Google Scholar 

  • Jones, N.F., Walker, G., Ruthven, C.R.J., Sandler, M.: Alphamethyl-p-tyrosine in the magnagement of phaeochromocytoma. Lancet1968 II, 1105–1109

    Google Scholar 

  • Pisano, J.J., Crout, J.R., Abraham, D.: Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin. Chim. Acta7, 285–291 (1962)

    PubMed  Google Scholar 

  • Pyörälä, K., Pitkänen, E., Toivonen, S.: Alpha-methyl-p-tyrosine in the symptomatic treatment of patients with malignant pheochromocytoma. Ann. Med. Intern. Fenn.57, 65–73 (1968)

    PubMed  Google Scholar 

  • Sato, T.L.: The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine. J. Lab. Clin. Med.66, 517–524 (1965)

    PubMed  Google Scholar 

  • Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by alpha-mathyl-tyrosine, an inhibitor to tyrosine hydroxylase. J. Pharmacol. exp. Ther.147, 86–95 (1965)

    PubMed  Google Scholar 

  • Waalkes, T.P., Udenfriend, S.: A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med.50, 733–741 (1957)

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hengstmann, J.H., Gugler, R. & Dengler, H.J. Malignant pheochromocytoma. Effect of oral α-methyl-p-tyrosine upon catecholamine metabolism. Klin Wochenschr 57, 351–355 (1979). https://doi.org/10.1007/BF01476565

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01476565

Schlüsselwörter

Key words

Navigation